Five self-limiting adverse events occurred (famotidine, n=2 (40%); placebo, n=3 (60% ... phase 2 clinical trial of oral famotidine (80 mg three times a day) and deeply profiled the enrolled diverse, ...

In a joint anti-encroachment drive on Tuesday, the Gurugram Metropolitan Development Authority (GMDA) and Municipal Corporation of Gurugram (MCG) demolished 40 illegal carts operating along MG ...

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

The results showed that both the oral insulin tablet and injectable Lantus substantially improved blood glucose levels and other efficacy parameters, with no significant differences between the ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.